Rechallenge After Oxaliplatin-Induced Hypersensitivity Reactions.
作者信息
Rassy Elie, Le Roy Florence, Smolenschi Cristina, Valéry Marine, Boige Valérie, Ducreux Michel, Boilève Alice
机构信息
Département de Médecine Oncologique, Gustave Roussy, Villejuif, France.
Service de Gastroentérologie, Groupe Hospitalier Bretagne Sud, Hôpital du Scorff, Lorient, France.
出版信息
JAMA Oncol. 2023 Mar 1;9(3):434-435. doi: 10.1001/jamaoncol.2022.7136.
Abstract
摘要
相似文献
1
Rechallenge After Oxaliplatin-Induced Hypersensitivity Reactions.奥沙利铂诱导的超敏反应后的再激发
JAMA Oncol. 2023 Mar 1;9(3):434-435. doi: 10.1001/jamaoncol.2022.7136.
2
Type II hypersensitivity reactions after oxaliplatin rechallenge can be life threatening.奥沙利铂再挑战后发生的 II 型超敏反应可能危及生命。
Int Immunopharmacol. 2019 Sep;74:105728. doi: 10.1016/j.intimp.2019.105728. Epub 2019 Jul 6.
3
Successful oxaliplatin desensitization protocol in a patient with colorectal metastatic cancer.成功的奥沙利铂脱敏方案在结直肠癌转移性癌症患者中的应用。
J Oncol Pharm Pract. 2021 Mar;27(2):490-493. doi: 10.1177/1078155220939143. Epub 2020 Jul 7.
4
Clinical Features of Oxaliplatin Induced Hypersensitivity Reactions and Therapeutic Approaches.奥沙利铂所致超敏反应的临床特征及治疗方法
Asian Pac J Cancer Prev. 2016;17(4):1637-41. doi: 10.7314/apjcp.2016.17.4.1637.
5
Oxaliplatin rechallenge in metastatic colorectal cancer patients after prior oxaliplatin treatment.奥沙利铂治疗转移性结直肠癌患者的再挑战。
Med Oncol. 2018 Apr 5;35(5):65. doi: 10.1007/s12032-018-1124-5.
6
Delayed hypersensitivity to oxaliplatin in a nigerian patient with colorectal cancer-A case report.尼日利亚结直肠癌患者奥沙利铂迟发性超敏反应：一例报告。
J Oncol Pharm Pract. 2021 Jul;27(5):1258-1260. doi: 10.1177/1078155220970631. Epub 2020 Nov 2.
7
Oxaliplatin immune-mediated thrombocytopenia: Is there a role for premedication or desensitization?奥沙利铂免疫介导性血小板减少症：是否需要预先用药或脱敏治疗？
Br J Clin Pharmacol. 2022 Feb;88(2):842-845. doi: 10.1111/bcp.14974. Epub 2021 Jul 29.
8
Hypersensitivity reactions to oxaliplatin: a retrospective study and the development of a desensitization protocol.对奥沙利铂的超敏反应：一项回顾性研究及脱敏方案的制定
Clin Colorectal Cancer. 2009 Apr;8(2):106-9.
9
Clinical Features of Oxaliplatin-induced Hypersensitivity Reactions in Chinese Patients: A Retrospective Multicenter Analysis.奥沙利铂所致过敏反应的临床特征：一项回顾性多中心分析。
Curr Med Sci. 2021 Aug;41(4):827-831. doi: 10.1007/s11596-021-2387-1. Epub 2021 Aug 17.
10
Retrospective evaluation of a rechallenge protocol in patients experiencing hypersensitivity reactions with prior chemotherapy in a tertiary hospital.对一家三级医院中曾因先前化疗出现过敏反应的患者进行再激发方案的回顾性评估。
J Oncol Pharm Pract. 2019 Sep;25(6):1388-1395. doi: 10.1177/1078155218796190. Epub 2018 Sep 4.
引用本文的文献
1
Independent risk and protective factors for oxaliplatin-induced hypersensitivity reactions: a retrospective study.奥沙利铂诱导的超敏反应的独立风险和保护因素：一项回顾性研究。
Front Pharmacol. 2025 Jul 8;16:1624322. doi: 10.3389/fphar.2025.1624322. eCollection 2025.
2
A real-world study of oxaliplatin-induced hypersensitivity in colorectal cancer treatment based on the pharmacovigilance system in China: a cohort study.基于中国药物警戒系统的结直肠癌治疗中奥沙利铂诱导超敏反应的真实世界研究：一项队列研究
J Gastrointest Oncol. 2025 Jun 30;16(3):978-985. doi: 10.21037/jgo-2025-312. Epub 2025 Jun 20.
3
Oxaliplatin desensitization for ovarian in pregnancy: A case report.孕期卵巢癌患者的奥沙利铂脱敏治疗：一例报告
Gynecol Oncol Rep. 2024 Feb 28;52:101354. doi: 10.1016/j.gore.2024.101354. eCollection 2024 Apr.
Zotero 插件